Company news

Imexpharm Corporation news in 2026

Imexpharm Corporation's news releases, calls and decks from 2026, newest first.

View company

IMP: Update Regulations on the Operation of the audit & Risk Management Committee

September 29, 2026

IMP: Update Regulations on the Internal Audit

September 29, 2026

IMP: Update Regulations on Supervision and Approval of related party transactions

September 29, 2026

IMP: The Board resolution dated September 7, 2026

September 6, 2026

IMP: Report on Corporate Governance for the first half of 2026

July 29, 2026

IMP: 2024 Annual Report

July 27, 2026

IMP: 2023 Annual Report

July 27, 2026

IMP: 2025 Annual Report

July 27, 2026

IMP: Record date for 2025 cash dividend payment

July 4, 2026

IMP: Notice of the record date for 2025 cash dividend payment

June 30, 2026

IMP: Approval of the record date for 2025 cash dividend payment

June 30, 2026

IMP: Change in personnel

June 29, 2026

IMP: Signing an audit contract for the 2026 financial statements

June 28, 2026

IMP: Minutes and Resolution of the General Meeting of Shareholders

June 23, 2026

IMP: Information related to the collection of shareholders’ written opinions

June 13, 2026

IMP: Approval of the list of candidates for members of the BOD

June 6, 2026

IMP: Record date for collecting shareholders' written opinions

May 28, 2026

IMP: Notice of the record date to collect shareholders’ written opinions

May 25, 2026

IMP: Notice of the nomination and candidacy for the BOD member position (2023-2027 term)

May 25, 2026

Decks in 2026